Publications

Seong Dong Jeong, Benjamin R. Schrank, James J. Mancuso, Betty Y.S. Kim, Wen Jiang, Padmanee Sharma; Translational Challenges and Opportunities in mRNA Cancer Vaccines. Cancer Discov 1 September 2026; 16 (9): 1739–1749. https://doi.org/10.1158/2159-8290.CD-25-1456

Carriere, P.P., Haisraely, O., Aaroe, A. et al. Long-term outcomes in IDH-wildtype (IDH-wt) gliomas with historical WHO grade 2 and 3 histology. J Neurooncol 179, 12 (2026). https://doi.org/10.1007/s11060-026-05712-2

Wang Y, Li S, Dong Y, Zhang J, Liu J, Wang Z, Liang S, Martinez NR, Pu H, Cheng P, Chen A, Yang Q, Chan CK, Jiang W, Xiao J, Guo F, Zhao L. Innate immune sensor NOD2 promotes cartilage degradation and osteoarthritis progression by stabilizing TRAF6 in chondrocytes. JCI Insight. 2026 Aug 24;11(16):e196750. doi: 10.1172/jci.insight.196750. PMID: 42635041; PMCID: PMC13502188.

Chang, M., Wang, Y., Ha, J. et al. A transferable gut microbiota–bile acid pathway programs nanomedicine pharmacokinetics and therapeutic response. Nat. Mater. 25, 1634–1645 (2026). https://doi.org/10.1038/s41563-026-02690-8

Wu, A., Jeong, S.D., Schrank, B.R. et al. Programming the immunological properties of mRNA vaccines for cancer. Nat Rev Immunol (2026). https://doi.org/10.1038/s41577-026-01316-z

Tian, Y., Liu, Y., Tong, Y. et al. Skeletal-muscle-targeted non-viral delivery of full-length DMD mRNA for Duchenne muscular dystrophy. Nat. Biomed. Eng (2026). https://doi.org/10.1038/s41551-026-01689-5

Ma, Y., Dong, S., Wu, A. et al. Engineering challenges and translational opportunities in emerging gene delivery platforms. Nat. Biomed. Eng 10, 1060–1083 (2026). https://doi.org/10.1038/s41551-026-01643-5

Ha, J., Wang, Y., Ma, Y. et al. Dual phagocytosis-checkpoint blockade revitalizes immune surveillance in mouse models of glioblastoma. Nat Commun 17, 3709 (2026). https://doi.org/10.1038/s41467-026-70221-9

Zhao, L., O’Donnell, K.L., Dubey, M. et al. Engineered mucus-tethering bispecific nanobodies enhance mucosal immunity against respiratory pathogens. Nat. Nanotechnol. 21, 419–429 (2026). https://doi.org/10.1038/s41565-025-02107-8

A. Zhang, Y. Ma, Y. Liu, et al. “ Mannose Oligosaccharide-Conjugated In Situ Pore-Forming Injectable Hydrogels for Rheumatoid Arthritis Treatment by Reprogramming Macrophage Extracellular Vesicles.” Small Methods 10, no. 3 (2026): 2500605. https://doi.org/10.1002/smtd.202500605

Qihang Ding, Lingbo Zhou, Tao Xiong, Jiqiang Liu, Luojia Chen, Jiyoung Yoo, Xiaoyu Xu, Xianglei Jia, Siling Chen, Siyu Chen, Yifan Wang, Ping Gong, Meijia Gu, Wen Jiang, Jong Seung Kim, Sunlight PDT leveraging NIR-II nanospray: painless, hemostatic, anti-inflammatory therapy towards diabetic wound infections, National Science Review, Volume 13, Issue 2, January 2026, nwaf554, https://doi.org/10.1093/nsr/nwaf554

Huan Zhang, Jianming Xing, Man Sun, Yaxin Cui, Yulai Li, Siyuan Hu, Xinhe Wang, Hao Jiang, Yun Zhang, Xuanjie Jiang, Fang Yang, Betty Y.S. Kim, Wen Jiang, Zhaogang Yang, Lesheng Teng, Engineered exosomes for targeted microRNA delivery to reverse liver fibrosis, Biomaterials, Volume 324, 2026, 123510, ISSN 0142-9612, https://doi.org/10.1016/j.biomaterials.2025.123510. 

Huan Zhang, Man Sun, Jiayi Chen, Simiao Wang, Jiayi Liu, Hongqun Yang, Luotong Liu, Siyuan Hu, Fang Yang, Lesheng Teng, Zhou Chen, Xiaobing Wang, Shiyan Dong, Yifan Ma, Jared L. Edwards, Xiaotian Wang, Yen-Tzu Chang, Betty Y.S. Kim, Wen Jiang, Yaxin Cui, Zhaogang Yang,Immunological conversion of triple-negative breast cancer by engineered extracellular vesicle-mediated pyroptosis, Journal of Controlled Release, Volume 389, 2026, 114493, ISSN 0168-3659, https://doi.org/10.1016/j.jconrel.2025.114493.

Grippin, A.J., Marconi, C., Copling, S. et al. SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockade. Nature 647, 488–497 (2025). https://doi.org/10.1038/s41586-025-09655-y

Alexander L. Ling et al. ,Serial multiomics uncovers anti-glioblastoma responses not evident by routine clinical analyses.Sci. Transl. Med. 17,eadv2881(2025).DOI:10.1126/scitranslmed.adv2881

M. Hou,Y. Ma,Y. Deng,Y. Wu,Y. Zhu,Y. Liu,X. Li,L. Yu,Z. He,Y. Wang,S. Dong,X. Xia,J. Yu,C. Yu,K. Kang,Y. Lu,L. Sun,B.Y.S. Kim,Y. Yuan,[...] & X. Zhu, Therapeutic restoration of mitochondria–endoplasmic reticulum cross talk for osteoarthritis, Proc. Natl. Acad. Sci. U.S.A. 122 (36) e2426992122, https://doi.org/10.1073/pnas.2426992122 (2025).

Pearce J, Basak A, Perni S ...Outcomes for Patients with High-Risk IDH-Mutant Grade 2 Gliomas Treated with IDH Inhibitors International Journal of Radiation Oncology, Biology, Physics, 123, e291-e292

M. Sun, H. Zhang, Y. Ma, et al. “ In Situ Programming of the Tumor Microenvironment to Alleviate Immunosuppression for Pancreatic Cancer Immunotherapy.” Adv. Sci. 12, no. 34 (2025): 12, e04008. https://doi.org/10.1002/advs.202504008

Grippin, A.J., Lee, D., Parkes, E.E. et al. Nanotechnology for immuno-oncology. Nat Cancer 6, 1311–1325 (2025). https://doi.org/10.1038/s43018-025-01025-x

Yeboa DN, Li J, Lin R, et al. Therapy, Safety, and Logistics of Preoperative vs Postoperative Stereotactic Radiation Therapy: A Preliminary Analysis of a Randomized Clinical Trial. JAMA Oncol. 2025;11(8):890–899. doi:10.1001/jamaoncol.2025.1770

Khorsandi, S., Huntoon, K., Wang, Y., Woodward, A., Antony, A., Endsley, C., Hafeez, N., Edwards, J.L., McCuen, N., Alluri, P.G., Kim, B.Y.S., Jiang, W. and Lux, J. (2025), Targeted STING Activation Using Modified Ultrasound-Responsive Microbubbles Enhances Immune Checkpoint Blockade Against Melanoma (Adv. Sci. 22/2025). Adv. Sci., 12: 2570173. https://doi.org/10.1002/advs.202570173

Yifan Wang, Haitao Song, Yue Teng, Guan Huang, Jingzhe Qian, Hongyu Wang, Shiyan Dong, JongHoon Ha, Yifan Ma, Mengyu Chang, Seong Dong Jeong, Weiye Deng, Benjamin R. Schrank, Adam Grippin, Annette Wu, Jared L. Edwards, Yixiang Zhang, Yuanyuan Lin, Wilson Poon, Stefan Wilhelm, Ye Bi, Lesheng Teng, Zikai Wang, Betty Y. S. Kim, Wen Jiang; A Generative Artificial Intelligence Copilot for Biomedical Nanoengineering. ACS Nano 27 May 2025; 19 (20): 19394–19407. https://doi.org/10.1021/acsnano.5c03454

Liu, Z., Wang, D., Li, G. et al. Neoadjuvant with low-dose radiotherapy, tislelizumab, albumin-bound paclitaxel, and cisplatin for resectable locally advanced head and neck squamous cell carcinoma: phase II single-arm trial. Nat Commun 16, 4608 (2025). https://doi.org/10.1038/s41467-025-59865-1

Yi You, Yu Tian, Rui Guo, Junfeng Shi, Kwang Joo Kwak, Yuhao Tong, Andreanne Poppy Estania, Wei-Hsiang Hsu, Yutong Liu, Shijun Hu, Jianhong Cao, Liqun Yang, Rui Bai, Pufeng Huang, Ly James Lee, Wen Jiang, Betty Y S Kim, Shuhong Ma, Xujie Liu, Zhenya Shen, Feng Lan, Patricia Kim Phuong Nguyen, Andrew S Lee, Extracellular vesicle-mediated VEGF-A mRNA delivery rescues ischaemic injury with low immunogenicity, European Heart Journal, Volume 46, Issue 17, 1 May 2025, Pages 1662–1676, https://doi.org/10.1093/eurheartj/ehae883

Tang, K., Tang, Z., Niu, M. et al. Allosteric targeted drug delivery for enhanced blood-brain barrier penetration via mimicking transmembrane domain interactions. Nat Commun 16, 3410 (2025). https://doi.org/10.1038/s41467-025-58746-x

Wang, Y., Xiao, Z., Wang, Z. et al. Multi-omics approaches to decipher the interactions of nanoparticles and biological systems. Nat Rev Bioeng 3, 333–348 (2025). https://doi.org/10.1038/s44222-024-00264-4

An antibody–toxin conjugate enhances innate immune cell responses in tumors. Nat Cancer 6, 415–416 (2025). https://doi.org/10.1038/s43018-025-00920-7

Schrank, B.R., Wang, Y., Wu, A. et al. An antibody–toxin conjugate targeting CD47 linked to the bacterial toxin listeriolysin O for cancer immunotherapy. Nat Cancer 6, 511–527 (2025). https://doi.org/10.1038/s43018-025-00919-0

F. Gao, X. Liu, Z. Ma, M. Tang, Z. Tang, J. Wu, M. Luo, Y. Tang, X. Wang, B. Wang, B. Y. Kim, Z. Yang, W. Jiang, P. Tang, C. Li, An Integrated Modular Vaccination System for Spatiotemporally Separated Perioperative Cancer Immunotherapy. Adv. Mater. 2025, 37, 2418322. https://doi.org/10.1002/adma.202418322

Yifan Ma, Shiyan Dong, Adam J. Grippin, Lesheng Teng, Andrew S. Lee, Betty Y.S. Kim, Wen Jiang, Engineering therapeutical extracellular vesicles for clinical translation, Trends in Biotechnology, Volume 43, Issue 1, 2025, Pages 61-82, ISSN 0167-7799, https://doi.org/10.1016/j.tibtech.2024.08.007.

Huan Zhang, Adam Grippin, Man Sun, Yifan Ma, Betty Y.S. Kim, Lesheng Teng, Wen Jiang, Zhaogang Yang,New avenues for cancer immunotherapy: Cell-mediated drug delivery systems, Journal of Controlled Release, Volume 375, 2024, Pages 712-732, ISSN 0168-3659, https://doi.org/10.1016/j.jconrel.2024.09.037.

Wang, Y., Schrank, B.R., Jiang, W. et al. Learning what keeps nanomedicines in tumours. Nat. Biomed. Eng 8, 1330–1331 (2024). https://doi.org/10.1038/s41551-024-01251-1

He, Y., Wang, Y., Wang, L., Jiang, W., & Wilhelm, S. (2024). Understanding nanoparticle-liver interactions in nanomedicine. Expert Opinion on Drug Delivery, 21(6), 829–843. https://doi.org/10.1080/17425247.2024.2375400

Thomas H Beckham, Michael K Rooney, Mary F McAleer, Amol J Ghia, Martin C Tom, Subha Perni, Susan McGovern, David Grosshans, Caroline Chung, Chenyang Wang, Brain De, Todd Swanson, Arnold Paulino, Wen Jiang, Sherise Ferguson, Chirag B Patel, Jing Li, Debra N Yeboa, Hypofractionated radiotherapy for glioblastoma: A large institutional retrospective assessment of 2 approaches, Neuro-Oncology Practice, Volume 11, Issue 3, June 2024, Pages 266–274, https://doi.org/10.1093/nop/npae004

JongHoon Ha, Adam J. Grippin, Betty Y.S. Kim, Wen Jiang; Striking the Balance with a PD-L1×4–1BB Bispecific Antibody. Cancer Res 15 May 2024; 84 (10): 1546–1547. https://doi.org/10.1158/0008-5472.CAN-24-0566

Bian, X., Yang, L., Jiang, D. et al. Regulation of cerebral blood flow boosts precise brain targeting of vinpocetine-derived ionizable-lipidoid nanoparticles. Nat Commun 15, 3987 (2024). https://doi.org/10.1038/s41467-024-48461-4

Lee, D., Huntoon, K., Wang, Y. et al. Synthetic cationic helical polypeptides for the stimulation of antitumour innate immune pathways in antigen-presenting cells. Nat. Biomed. Eng 8, 593–610 (2024). https://doi.org/10.1038/s41551-024-01194-7

Lili Sun, Haoyi Niu, Yuqiong Wu, Shiyan Dong, Xuefeng Li, Betty Y.S. Kim, Changsheng Liu, Yifan Ma, Wen Jiang, Yuan Yuan, Bio-integrated scaffold facilitates large bone regeneration dominated by endochondral ossification, Bioactive Materials, Volume 35, 2024, Pages 208-227, ISSN 2452-199X, https://doi.org/10.1016/j.bioactmat.2024.01.019.

Lee D, Huntoon K, Wang Y, Kang M, Lu Y, Jeong SD, Link TM, Gallup TD, Qie Y, Li X, Dong S, Schrank BR, Grippin AJ, Antony A, Ha J, Chang M, An Y, Wang L, Jiang D, Li J, Koong AC, Tainer JA, Jiang W, Kim BYS. Synthetic cationic helical polypeptides for the stimulation of antitumour innate immune pathways in antigen-presenting cells. Nat Biomed Eng. 2024 May;8(5):593-610. doi: 10.1038/s41551-024-01194-7. Epub 2024 Apr 19. PMID: 38641710; PMCID: PMC11162332.

Mengyu Chang, Man Wang, Bin Liu, Wenbin Zhong, Deblin Jana, Yifan Wang, Shiyan Dong, Abin Antony, Chunxia Li, Yuhui Liu, Zhongqi Zhao, Jun Lin, Wen Jiang, Yanli Zhao; A Cancer Nanovaccine Based on an FeAl-Layered Double Hydroxide Framework for Reactive Oxygen Species-Augmented Metalloimmunotherapy. ACS Nano 19 March 2024; 18 (11): 8143–8156. https://doi.org/10.1021/acsnano.3c11960

Xuefeng Li, Kristin Huntoon, Yifan Wang, DaeYong Lee, Shiyan Dong, Abin Antony, Carl Walkey, Betty Y.S. Kim, Wen Jiang; Radiation Synergizes with IL2/IL15 Stimulation to Enhance Innate Immune Activation and Antitumor Immunity. Mol Cancer Ther 1 March 2024; 23 (3): 330–342. https://doi.org/10.1158/1535-7163.MCT-23-0236

Wang, Y., Deng, W., Lee, D. et al. Age-associated disparity in phagocytic clearance affects the efficacy of cancer nanotherapeutics. Nat. Nanotechnol. 19, 255–263 (2024). https://doi.org/10.1038/s41565-023-01502-3

• Huntoon K, Anderson SK, Ballman KV, Twohy E, Dooley K, Jiang W, An Y, Li J, von Roemeling C, Qie Y, Ross OA, Cerhan JH, Whitton AC, Greenspoon JN, Parney IF, Ashman JB, Bahary JP, Hadjipanayis C, Urbanic JJ, Farace E, Khuntia D, Laack NN, Brown PD, Roberge D, Kim BYS. Association of circulating markers with cognitive decline after radiation therapy for brain metastasis. Neuro Oncol. 2023 Jun 2;25(6):1123-1131. doi: 10.1093/neuonc/noac262. PubMed PMID: 36472389; PubMed Central PMCID: PMC10237411.
• Huntoon K, Jiang W, Kim BY. Waking immune-resistant tumors with neddylation. J Clin Invest. 2023 Feb 15;133(4). doi: 10.1172/JCI167894. PubMed PMID: 36787255; PubMed Central PMCID: PMC9927922.
• You Y, Tian Y, Yang Z, Shi J, Kwak KJ, Tong Y, Estania AP, Cao J, Hsu WH, Liu Y, Chiang CL, Schrank BR, Huntoon K, Lee D, Li Z, Zhao Y, Zhang H, Gallup TD, Ha J, Dong S, Li X, Wang Y, Lu WJ, Bahrani E, Lee LJ, Teng L, Jiang W, Lan F, Kim BYS, Lee AS. Intradermally delivered mRNA-encapsulating extracellular vesicles for collagen-replacement therapy. Nat Biomed Eng. 2023 Jan 12;. doi: 10.1038/s41551-022-00989-w. [Epub ahead of print] PubMed PMID: 36635419.

• Lu Y, Huntoon K, Lee D, Wang Y, Ha J, Qie Y, Li X, Schrank BR, Dong S, Gallup TD, Kang M, Zhao H, An Y, Yang Z, Li J, Kim BYS, Jiang W. Immunological conversion of solid tumours using a bispecific nanobioconjugate for cancer immunotherapy. Nat Nanotechnol. 2022 Dec;17(12):1332-1341. doi: 10.1038/s41565-022-01245-7. Epub 2022 Nov 10. PubMed PMID: 36357792; PubMed Central PMCID: PMC10036139.
• Huang X, Liu Q, Zhong G, Peng Y, Liu Y, Liang L, Hong H, Feng W, Yang S, Zhang Y, Xian S, Li Z, Zhou Y, Zhang Z, Jiang W, Liang J, Liu ZG. Neoadjuvant toripalimab combined with gemcitabine and cisplatin in resectable locally advanced head and neck squamous cell carcinoma (NeoTGP01): An open label, single-arm, phase Ib clinical trial. J Exp Clin Cancer Res. 2022 Oct 12;41(1):300. doi: 10.1186/s13046-022-02510-2. PubMed PMID: 36224603; PubMed Central PMCID: PMC9558942.
• Li X, Khorsandi S, Wang Y, Santelli J, Huntoon K, Nguyen N, Yang M, Lee D, Lu Y, Gao R, Kim BYS, de Gracia Lux C, Mattrey RF, Jiang W, Lux J. Cancer immunotherapy based on image-guided STING activation by nucleotide nanocomplex-decorated ultrasound microbubbles. Nat Nanotechnol. 2022 Aug;17(8):891-899. doi: 10.1038/s41565-022-01134-z. Epub 2022 May 30. PubMed PMID: 35637356; PubMed Central PMCID: PMC9378430.
• Li J, Xue C, Wang H, Dong S, Yang Z, Cao Y, Zhao B, Cheng B, Xie X, Mo X, Jiang W, Yuan H, Pan J. Hybrid Nanofibrous Composites with Anisotropic Mechanics and Architecture for Tendon/Ligament Repair and Regeneration. Small. 2022 Jul;18(27):e2201147. doi: 10.1002/smll.202201147. Epub 2022 Jun 9. PubMed PMID: 35686342.
• George J, Chen Y, Abdelfattah N, Yamamoto K, Gallup TD, Adamson SI, Rybinski B, Srivastava A, Kumar P, Lee MG, Baskin DS, Jiang W, Choi JM, Flavahan W, Chuang JH, Kim BY, Xu J, Jung SY, Yun K. Cancer stem cells, not bulk tumor cells, determine mechanisms of resistance to SMO inhibitors. Cancer Res Commun. 2022 Jun;2(6):402-416. doi: 10.1158/2767-9764.crc-22-0124. Epub 2022 Jun 6. PubMed PMID: 36688010; PubMed Central PMCID: PMC9853917.
• Hein DM, Deng W, Bleile M, Kazmi SA, Rhead B, De La Vega FM, Jones AL, Kainthla R, Jiang W, Cantarel B, Sanford NN. Racial and Ethnic Differences in Genomic Profiling of Early Onset Colorectal Cancer. J Natl Cancer Inst. 2022 May 9;114(5):775-778. doi: 10.1093/jnci/djac014. PubMed PMID: 35134211; PubMed Central PMCID: PMC9086761.
• Dong S, Bi Y, Sun X, Zhao Y, Sun R, Hao F, Sun Y, Wang Y, Li X, Deng W, Liu X, Ha J, Teng L, Gong P, Xie J, Kim BYS, Yang Z, Jiang W, Teng L. Dual-Loaded Liposomes Tagged with Hyaluronic Acid Have Synergistic Effects in Triple-Negative Breast Cancer. Small. 2022 Apr;18(16):e2107690. doi: 10.1002/smll.202107690. Epub 2022 Mar 11. PubMed PMID: 35277914.
• Abdelfattah N, Kumar P, Wang C, Leu JS, Flynn WF, Gao R, Baskin DS, Pichumani K, Ijare OB, Wood SL, Powell SZ, Haviland DL, Parker Kerrigan BC, Lang FF, Prabhu SS, Huntoon KM, Jiang W, Kim BYS, George J, Yun K. Single-cell analysis of human glioma and immune cells identifies S100A4 as an immunotherapy target. Nat Commun. 2022 Feb 9;13(1):767. doi: 10.1038/s41467-022-28372-y. PubMed PMID: 35140215; PubMed Central PMCID: PMC8828877.

• Yu S, Wei S, Savani M, Lin X, Du K, Mender I, Siteni S, Vasilopoulos T, Reitman ZJ, Ku Y, Wu D, Liu H, Tian M, Chen Y, Labrie M, Charbonneau CM, Sugarman E, Bowie M, Hariharan S, Waitkus M, Jiang W, McLendon RE, Pan E, Khasraw M, Walsh KM, Lu Y, Herlyn M, Mills G, Herbig U, Wei Z, Keir ST, Flaherty K, Liu L, Wu K, Shay JW, Abdullah K, Zhang G, Ashley DM. A Modified Nucleoside 6-Thio-2'-Deoxyguanosine Exhibits Antitumor Activity in Gliomas. Clin Cancer Res. 2021 Dec 15;27(24):6800-6814. doi: 10.1158/1078-0432.CCR-21-0374. Epub 2021 Sep 30. PubMed PMID: 34593527; PubMed Central PMCID: PMC8678347.
• Sun Z, Deng G, Peng X, Xu X, Liu L, Peng J, Ma Y, Zhang P, Wen A, Wang Y, Yang Z, Gong P, Jiang W, Cai L. Intelligent photothermal dendritic cells restart the cancer immunity cycle through enhanced immunogenic cell death. Biomaterials. 2021 Dec;279:121228. doi: 10.1016/j.biomaterials.2021.121228. Epub 2021 Oct 26. PubMed PMID: 34717198.
• Liu M, Wu K, Lin J, Xie Q, Liu Y, Huang Y, Zeng J, Yang Z, Wang Y, Dong S, Deng W, Yang M, Wu S, Jiang W, Li X. Emerging Biological Functions of IL-17A: A New Target in Chronic Obstructive Pulmonary Disease?. Front Pharmacol. 2021;12:695957. doi: 10.3389/fphar.2021.695957. eCollection 2021. Review. PubMed PMID: 34305606; PubMed Central PMCID: PMC8294190.
• Lee D, Huntoon K, Wang Y, Jiang W, Kim BYS. Harnessing Innate Immunity Using Biomaterials for Cancer Immunotherapy. Adv Mater. 2021 Jul;33(27):e2007576. doi: 10.1002/adma.202007576. Epub 2021 May 29. Review. PubMed PMID: 34050699.
• Liu Y, Yang Z, Wang L, Sun L, Kim BYS, Jiang W, Yuan Y, Liu C. Spatiotemporal Immunomodulation Using Biomimetic Scaffold Promotes Endochondral Ossification-Mediated Bone Healing. Adv Sci (Weinh). 2021 Jun;8(11):e2100143. doi: 10.1002/advs.202100143. Epub 2021 Mar 16. PubMed PMID: 34105266; PubMed Central PMCID: PMC8188258.
• Zhang N, Yin R, Zhou P, Liu X, Fan P, Qian L, Dong L, Zhang C, Zheng X, Deng S, Kuai J, Liu Z, Jiang W, Wang X, Wu D, Huang Y. DLL1 orchestrates CD8+ T cells to induce long-term vascular normalization and tumor regression. Proc Natl Acad Sci U S A. 2021 Jun 1;118(22). doi: 10.1073/pnas.2020057118. PubMed PMID: 34035167; PubMed Central PMCID: PMC8179177.
• Sun X, Yu K, Zhou Y, Dong S, Hu W, Sun Y, Li Y, Xie J, Lee RJ, Sun F, Ma Y, Wang S, Kim BYS, Wang Y, Yang Z, Jiang W, Li Y, Teng L. Self-Assembled pH-Sensitive Polymeric Nanoparticles for the Inflammation-Targeted Delivery of Cu/Zn-Superoxide Dismutase. ACS Appl Mater Interfaces. 2021 Apr 21;13(15):18152-18164. doi: 10.1021/acsami.1c03589. Epub 2021 Mar 25. PubMed PMID: 33764751.
• Xie S, Shalaby-Rana E, Hester A, Honeycutt J, Fu CL, Boyett D, Jiang W, Hsieh MH. Macroscopic and microscopic imaging modalities for diagnosis and monitoring of urogenital schistosomiasis. Adv Parasitol. 2021;112:51-76. doi: 10.1016/bs.apar.2021.01.001. Epub 2021 Mar 11. Review. PubMed PMID: 34024359.
• Ma Y, Dong S, Li X, Kim BYS, Yang Z, Jiang W. Extracellular Vesicles: An Emerging Nanoplatform for Cancer Therapy. Front Oncol. 2020;10:606906. doi: 10.3389/fonc.2020.606906. eCollection 2020. Review. PubMed PMID: 33628730; PubMed Central PMCID: PMC7897670.
• Jiang W, Wang Y, Wargo JA, Lang FF, Kim BYS. Considerations for designing preclinical cancer immune nanomedicine studies. Nat Nanotechnol. 2021 Jan;16(1):6-15. doi: 10.1038/s41565-020-00817-9. Epub 2020 Dec 21. Review. PubMed PMID: 33349682; PubMed Central PMCID: PMC8103921.
   

• Hong WX, Haebe S, Lee AS, Westphalen CB, Norton JA, Jiang W, Levy R. Intratumoral Immunotherapy for Early-stage Solid Tumors. Clin Cancer Res. 2020 Jul 1;26(13):3091-3099. doi: 10.1158/1078-0432.CCR-19-3642. Epub 2020 Feb 18. Review. PubMed PMID: 32071116; PubMed Central PMCID: PMC7439755.
• Li Q, Wang Y, Jia W, Deng H, Li G, Deng W, Chen J, Kim BYS, Jiang W, Liu Q, Liu J. Low-Dose Anti-Angiogenic Therapy Sensitizes Breast Cancer to PD-1 Blockade. Clin Cancer Res. 2020 Apr 1;26(7):1712-1724. doi: 10.1158/1078-0432.CCR-19-2179. Epub 2019 Dec 17. PubMed PMID: 31848190.
• von Roemeling CA, Wang Y, Qie Y, Yuan H, Zhao H, Liu X, Yang Z, Yang M, Deng W, Bruno KA, Chan CK, Lee AS, Rosenfeld SS, Yun K, Johnson AJ, Mitchell DA, Jiang W, Kim BYS. Therapeutic modulation of phagocytosis in glioblastoma can activate both innate and adaptive antitumour immunity. Nat Commun. 2020 Mar 20;11(1):1508. doi: 10.1038/s41467-020-15129-8. PubMed PMID: 32198351; PubMed Central PMCID: PMC7083893.
• Yang Z, Shi J, Xie J, Wang Y, Sun J, Liu T, Zhao Y, Zhao X, Wang X, Ma Y, Malkoc V, Chiang C, Deng W, Chen Y, Fu Y, Kwak KJ, Fan Y, Kang C, Yin C, Rhee J, Bertani P, Otero J, Lu W, Yun K, Lee AS, Jiang W, Teng L, Kim BYS, Lee LJ. Large-scale generation of functional mRNA-encapsulating exosomes via cellular nanoporation. Nat Biomed Eng. 2020 Jan;4(1):69-83. doi: 10.1038/s41551-019-0485-1. Epub 2019 Dec 16. PubMed PMID: 31844155; PubMed Central PMCID: PMC7080209.

• Zheng X, Zhang N, Qian L, Wang X, Fan P, Kuai J, Lin S, Liu C, Jiang W, Qin S, Chen H, Huang Y. CTLA4 blockade promotes vessel normalization in breast tumors via the accumulation of eosinophils. Int J Cancer. 2020 Mar 15;146(6):1730-1740. doi: 10.1002/ijc.32829. Epub 2019 Dec 28. PubMed PMID: 31840816.
• Meng F, Sun Y, Lee RJ, Wang G, Zheng X, Zhang H, Fu Y, Yan G, Wang Y, Deng W, Parks E, Kim BYS, Yang Z, Jiang W, Teng L. Folate Receptor-Targeted Albumin Nanoparticles Based on Microfluidic Technology to Deliver Cabazitaxel. Cancers (Basel). 2019 Oct 16;11(10). doi: 10.3390/cancers11101571. PubMed PMID: 31623082; PubMed Central PMCID: PMC6827099.
• Feng M, Jiang W, Kim BYS, Zhang CC, Fu YX, Weissman IL. Phagocytosis checkpoints as new targets for cancer immunotherapy. Nat Rev Cancer. 2019 Oct;19(10):568-586. doi: 10.1038/s41568-019-0183-z. Epub 2019 Aug 28. Review. PubMed PMID: 31462760; PubMed Central PMCID: PMC7002027.
• Li N, Wang Y, Neri S, Zhen Y, Fong LWR, Qiao Y, Li X, Chen Z, Stephan C, Deng W, Ye R, Jiang W, Zhang S, Yu Y, Hung MC, Chen J, Lin SH. Tankyrase disrupts metabolic homeostasis and promotes tumorigenesis by inhibiting LKB1-AMPK signalling. Nat Commun. 2019 Sep 25;10(1):4363. doi: 10.1038/s41467-019-12377-1. PubMed PMID: 31554794; PubMed Central PMCID: PMC6761205.
• Liu Z, Wang Y, Huang Y, Kim BYS, Shan H, Wu D, Jiang W. Tumor Vasculatures: A New Target for Cancer Immunotherapy. Trends Pharmacol Sci. 2019 Sep;40(9):613-623. doi: 10.1016/j.tips.2019.07.001. Epub 2019 Jul 20. Review. PubMed PMID: 31331639; PubMed Central PMCID: PMC7925217.
• Yang Z, Wang L, Yu H, Wang R, Gou Y, Zhang M, Kang C, Liu T, Lan Y, Wang X, Liu J, Cooper MA, Li X, Yue K, Yu Y, Wang L, Kim BYS, Jiang W, Sun W. Membrane TLR9 Positive Neutrophil Mediated MPLA Protects Against Fatal Bacterial Sepsis. Theranostics. 2019;9(21):6269-6283. doi: 10.7150/thno.37139. eCollection 2019. PubMed PMID: 31534550; PubMed Central PMCID: PMC6735515.
• Leong HS, Butler KS, Brinker CJ, Azzawi M, Conlan S, Dufés C, Owen A, Rannard S, Scott C, Chen C, Dobrovolskaia MA, Kozlov SV, Prina-Mello A, Schmid R, Wick P, Caputo F, Boisseau P, Crist RM, McNeil SE, Fadeel B, Tran L, Hansen SF, Hartmann NB, Clausen LPW, Skjolding LM, Baun A, Ågerstrand M, Gu Z, Lamprou DA, Hoskins C, Huang L, Song W, Cao H, Liu X, Jandt KD, Jiang W, Kim BYS, Wheeler KE, Chetwynd AJ, Lynch I, Moghimi SM, Nel A, Xia T, Weiss PS, Sarmento B, das Neves J, Santos HA, Santos L, Mitragotri S, Little S, Peer D, Amiji MM, Alonso MJ, Petri-Fink A, Balog S, Lee A, Drasler B, Rothen-Rutishauser B, Wilhelm S, Acar H, Harrison RG, Mao C, Mukherjee P, Ramesh R, McNally LR, Busatto S, Wolfram J, Bergese P, Ferrari M, Fang RH, Zhang L, Zheng J, Peng C, Du B, Yu M, Charron DM, Zheng G, Pastore C. On the issue of transparency and reproducibility in nanomedicine. Nat Nanotechnol. 2019 Jul;14(7):629-635. doi: 10.1038/s41565-019-0496-9. PubMed PMID: 31270452; PubMed Central PMCID: PMC6939883.
• Liu Z, Xu C, Jiang R, Liu G, Liu Q, Zhou J, Liu F, Yao J, Wang S, Jiang W. Treatment of Locally Advanced Nasopharyngeal Carcinoma by Helical Tomotherapy: An Observational, Prospective Analysis. Transl Oncol. 2019 May;12(5):757-763. doi: 10.1016/j.tranon.2019.02.011. Epub 2019 Mar 15. PubMed PMID: 30878894; PubMed Central PMCID: PMC6423362.
• Wang Y, Liu ZG, Yuan H, Deng W, Li J, Huang Y, Kim BYS, Story MD, Jiang W. The Reciprocity between Radiotherapy and Cancer Immunotherapy. Clin Cancer Res. 2019 Mar 15;25(6):1709-1717. doi: 10.1158/1078-0432.CCR-18-2581. Epub 2018 Nov 9. Review. PubMed PMID: 30413527; PubMed Central PMCID: PMC6420874.
• Chen Y, Liu X, Yuan H, Yang Z, von Roemeling CA, Qie Y, Zhao H, Wang Y, Jiang W, Kim BYS. Therapeutic Remodeling of the Tumor Microenvironment Enhances Nanoparticle Delivery. Adv Sci (Weinh). 2019 Mar 6;6(5):1802070. doi: 10.1002/advs.201802070. eCollection 2019 Mar 6. PubMed PMID: 30886813; PubMed Central PMCID: PMC6402396.
• Liu Y, Song Y, Lin D, Lei L, Mei Y, Jin Z, Gong H, Zhu Y, Hu B, Zhang Y, Zhao L, Teo HY, Qiu J, Jiang W, Dong C, Wu D, Huang Y, Liu H. NCR- group 3 innate lymphoid cells orchestrate IL-23/IL-17 axis to promote hepatocellular carcinoma development. EBioMedicine. 2019 Mar;41:333-344. doi: 10.1016/j.ebiom.2019.02.050. Epub 2019 Mar 1. PubMed PMID: 30827928; PubMed Central PMCID: PMC6443584.